LY9 and nodal marginal zone B-cell lymphoma: High expression of CD229 was found in nodal marginal-zone lymphoma (NMZL) (82%), mucosa-associated lymphoid tissue lymphoma (MALT) (86%), and splenic marginal-zone lymphoma (SMZL) (87%) (Table 1 and Figure 4).